Published in J Neurol Neurosurg Psychiatry on January 01, 1991
Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol (1985) 2.10
Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology (1980) 1.60
'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain (1977) 1.56
Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol (1989) 1.24
Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30-year evaluation of clinical and neuropathologic trends. Neurology (1986) 1.17
Neurofibrillary change on Guam. Arch Neurol (1981) 0.98
Insect-sting encephalopathy. Br Med J (Clin Res Ed) (1982) 0.96
Humoral immunity in Guamanians with amyotrophic lateral sclerosis and parkinsonism-dementia. Ann Neurol (1981) 0.85
Amyotrophic lateral sclerosis of the Guam type in a U.S. veteran. Neurology (1973) 0.84
The postviral fatigue syndrome--an analysis of the findings in 50 cases. J Infect (1985) 4.39
Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ (1991) 3.65
Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ (1992) 2.64
Myalgic encephalomyelitis--report of an epidemic. J R Coll Gen Pract (1983) 2.64
Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J R Soc Med (1988) 2.60
Epidemic myalgic encephalomyelitis. Practitioner (1980) 2.53
Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet (1976) 2.31
The symptoms of chronic fatigue syndrome are related to abnormal ion channel function. Med Hypotheses (2000) 2.10
Fatigue and basal ganglia. J Neurol Sci (2000) 1.82
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection. Clin Infect Dis (2001) 1.72
Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome. BMJ (1991) 1.69
'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain (1977) 1.56
Myasthenic crisis. QJM (2008) 1.52
Serum folate and chronic fatigue syndrome. Neurology (1993) 1.47
Gangliosides and neurological diseases. BMJ (1992) 1.43
Acute cervical hyperextension-hyperflexion injury may precipitate and/or exacerbate symptomatic multiple sclerosis. Eur J Neurol (2001) 1.37
Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis. Neurology (1974) 1.35
Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry (1990) 1.26
Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol (1991) 1.22
Landry-Guillain-Barré-Strohl syndrome and immune-complex nephritis. Lancet (1973) 1.22
Neurological dysfunction in two patients receiving captopril and cimetidine. Lancet (1980) 1.20
Immune disease and HLA associations with myasthenia gravis. J Neurol Neurosurg Psychiatry (1980) 1.17
Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis. Lancet (1968) 1.17
Neurological aspects of mycoplasmal infection. Acta Neurol Scand (1986) 1.16
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol (1991) 1.11
The social impact of multiple sclerosis--a study of 305 patients and their relatives. Disabil Rehabil (2000) 1.08
Dysphagia in Parkinson's disease. Eur Neurol (1997) 1.07
Palatal myoclonus successfully treated with clonazepam. J Neurol Neurosurg Psychiatry (1990) 1.07
Clinical spectrum of postviral fatigue syndrome. Br Med Bull (1991) 1.04
Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type. Ann N Y Acad Sci (1976) 1.04
Letter: Immune response genes in myasthenia gravis. Lancet (1973) 1.02
Allergic encephalomyelitis: effect of complement depletion with cobra venom. Proc Soc Exp Biol Med (1971) 1.02
Immunologic mechanisms in experimental encephalomyelitis in nonhuman primates. Arch Neurol (1973) 1.00
In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids (2004) 0.99
Letter: Impaired cell-mediated immunity in human brain tumours. Lancet (1975) 0.98
Search for retrovirus in the chronic fatigue syndrome. J Clin Pathol (1992) 0.97
GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient. J Autoimmun (1999) 0.96
Letter: Rosette tests following thymectomy. Lancet (1975) 0.96
Evaluation of the benefits of monitoring fluid thickness in the dietary management of dysphagic stroke patients. Clin Rehabil (2000) 0.95
Does pulse oximetry reliably detect aspiration in dysphagic stroke patients? Stroke (1997) 0.95
Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis. Lancet (1979) 0.95
Late onset of Guillain-Barré syndrome. J Neuroimmunol (1982) 0.95
A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. Br J Clin Pharmacol (1990) 0.95
Nifedipine in the treatment of myotonia in myotonic dystrophy. J Neurol Neurosurg Psychiatry (1987) 0.95
HLA-B8 in polymyositis. N Engl J Med (1978) 0.95
Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases. J Neurol Neurosurg Psychiatry (1997) 0.94
The role of viral infection in polymyositis, dermatomyositis and chronic fatigue syndrome. Baillieres Clin Neurol (1993) 0.93
Cell-mediated hypersensitivity to neural antigens. Occurrence in human patients and nonhuman primates with neurological diseases. Arch Neurol (1972) 0.93
A case of progressive encephalomyelitis with rigidity and positive antiglutamic acid decarboxylase antibodies [corrected]. J Neurol Neurosurg Psychiatry (1991) 0.93
Immunological features of polymyositis/dermatomyositis. Springer Semin Immunopathol (1985) 0.92
Hyperacute experimental allergic neuritis. Res Commun Chem Pathol Pharmacol (1971) 0.91
Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann N Y Acad Sci (2002) 0.91
Immunopathological mechanisms of allergic neuritis in animals, primates, and man. Trans Am Neurol Assoc (1969) 0.91
The ophthalmoplegic form of the Guillain-Barre-syndrome: an immunologic study. Acta Ophthalmol (Copenh) (1973) 0.91
Recurrent acute necrotizing hemorrhagic incephalopathy. Acta Neuropathol (1972) 0.90
Acute disseminated encephalomyelitis. Br J Clin Pract (1974) 0.89
Diffuse myelitis associated with rubella vaccination. Br Med J (1977) 0.88
Acute necrotizing hemorrhagic encephalopathy. Postgrad Med (1973) 0.88
Hereditary chorea without dementia. J Neurol Neurosurg Psychiatry (1977) 0.88
Behavioural problems associated with the chronic fatigue syndrome. Br J Psychol (1993) 0.88
Brain damage complicating septic shock: acute haemorrhagic leucoencephalitis as a complication of the generalised Shwartzman reaction. J Neurol Neurosurg Psychiatry (1979) 0.87
Disturbance of regulatory lymphocyte subsets in polymyositis. Ann Neurol (1984) 0.87
Metabolism of immunoglobulin A, lymphocyte function, and histocompatibility antigens in patients on anticonvulsants. J Neurol Neurosurg Psychiatry (1978) 0.87
Studies on enterovirus in patients with chronic fatigue syndrome. Clin Infect Dis (1994) 0.86
Enterovirus in the chronic fatigue syndrome. Ann Intern Med (1994) 0.86
Neuroanatomical anomalies in autoimmune mice. Acta Neuropathol (1987) 0.86
Brain abnormalities in immune defective mice. Brain Res (1990) 0.86
Treatment of multiple sclerosis: beyond the NICE guidelines. QJM (2005) 0.85
Letter: Decreased serum-IgA in myasthenia gravis. Lancet (1976) 0.85
Experimental autoimmune demyelinating diseases: experimental allergic encephalomyelitis and experimental allergic neuritis. Biomedicine (1975) 0.85
A study of the factors which influence the length of hospital stay of stroke patients. Clin Rehabil (1998) 0.85
Effects of the autoimmune uterine/maternal environment upon cortical ectopias, behavior and autoimmunity. Brain Res (1991) 0.84
Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins. Br Heart J (1987) 0.84
Rat or human acetylcholine-receptor antigen for investigation of myasthenia gravis? Lancet (1979) 0.84
A behavior profile of the MRL/Mp lpr/lpr mouse and its association with hydrocephalus. Brain Behav Immun (1992) 0.84
Does Toxoplasma cause polymyositis? Report of a case of polymyositis associated with toxoplasmosis and a critical review of the literature. Acta Neuropathol (1983) 0.83
Bilateral internuclear ophthalmoplegia as a false localizing sign. J R Soc Med (1991) 0.82
Histocompatibility antigens associated with motor-neurone disease. Lancet (1976) 0.82
The inflammatory process in polymyositis: monoclonal antibody analysis of muscle and peripheral blood immunoregulatory lymphocytes. J Neurol Neurosurg Psychiatry (1987) 0.82
The prevalence of verbal communication disability in patients with Parkinson's disease. Disabil Rehabil (1997) 0.82
Long RT-PCR amplification of full-length enterovirus genome. Biotechniques (1996) 0.81
Complement abnormalities in polymyositis. J Neurol Sci (1977) 0.81
Experimental allergic neuritis: a new experimental approach. J Neurol Neurosurg Psychiatry (1973) 0.81
Abnormalities of lymphocyte subsets in polymyositis. Br Med J (Clin Res Ed) (1983) 0.81
Lymphocyte subset abnormalities in patients with spasmodic torticollis. Acta Neurol Scand (1986) 0.80
Interferon in treatment of subacute sclerosing panencephalitis. Lancet (1981) 0.80
Peripheral nervous tissue injury induced by galactocerebroside and galactocerebroside immune complexes. Acta Neuropathol (1985) 0.80
Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders. Acta Neuropathol (1982) 0.80
Lymphocyte transformation in the Guillain-Barré syndrome. Lancet (1970) 0.80
Detection of immune complexes in polymyositis. Acta Neurol Scand (1982) 0.80
Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis. J Neurol Neurosurg Psychiatry (1975) 0.80
Immune complexes in myasthenia gravis. J Neurol Neurosurg Psychiatry (1979) 0.79
Transfer-factor therapy in multiple sclerosis. Lancet (1976) 0.79
Similarities between the Forssman carotid syndrome and experimental allergic encephalomyelitis. Acta Neuropathol (1986) 0.79
Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy. J Neurol Neurosurg Psychiatry (1980) 0.79
Subacute Wernicke's encephalopathy due to gastric syphilis. Br J Vener Dis (1981) 0.79
Pathogenesis of heart block in a fatal case of dermatomyositis. Br Heart J (1986) 0.79